| Not Yet Recruiting | PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation The NCT07327515 | Li Min | N/A |
| Not Yet Recruiting | 125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors NCT07277777 | Li Min | Phase 2 |
| Not Yet Recruiting | Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outc NCT07201259 | West China Second University Hospital | — |
| Recruiting | A Study of LM-350 in Subjects With Advanced Solid Tumours NCT07112222 | LaNova Medicines Limited | Phase 1 / Phase 2 |
| Not Yet Recruiting | The Predictive Value of Serum Histone Succinylation in Malignant Solid Tumors NCT07132606 | Yinghua Ji | — |
| Recruiting | Clinical Application of 68Ga-FL-031 PET in the Diagnosis and Staging of Malignant Tumors NCT07301801 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | EARLY_Phase 1 |
| Recruiting | Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies NCT07004244 | Sichuan University | Phase 1 |
| Recruiting | A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors NCT06944444 | Shenyang Sunshine Pharmaceutical Co., LTD. | Phase 1 |
| Not Yet Recruiting | Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Stud NCT06753513 | Zhejiang University | — |
| Recruiting | Study of LM-299 in Subjects Advanced Malignant Tumors NCT06650566 | LaNova Medicines Limited | Phase 1 / Phase 2 |
| Active Not Recruiting | Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors NCT05714748 | West China Hospital | Phase 1 |
| Recruiting | A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors NCT05615974 | LaNova Medicines Limited | Phase 1 / Phase 2 |
| Completed | A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors NCT05516914 | Nanjing Leads Biolabs Co.,Ltd | Phase 1 / Phase 2 |
| Completed | FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Applica NCT06270394 | The First Affiliated Hospital of Anhui Medical University | N/A |
| Unknown | BBPA PET/CT in Patients With Malignant Tumors NCT05987098 | Peking Union Medical College Hospital | N/A |
| Unknown | CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors NCT04702841 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | EARLY_Phase 1 |
| Completed | The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases NCT06740175 | University Medical Center Groningen | N/A |
| Completed | Clinical Study of Pretreatment PET/CT Parameters for Predicting the Efficacy of 125I Seed Implantation in the NCT07208487 | Jiangxi Provincial Cancer Hospital | — |
| Unknown | Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors NCT03160599 | Second Affiliated Hospital of Guangzhou Medical University | N/A |
| Completed | Bioseal Dural Sealing Study BIOS-14-001 NCT03110783 | Guangzhou Bioseal Biotechnology Co., Ltd. | Phase 3 |
| Completed | Usefulness of Gadovist-enhanced FLAIR Imaging NCT05293990 | Ryoo, In Seon | N/A |
| Completed | Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors NCT02534506 | Bristol-Myers Squibb | Phase 1 |
| Completed | Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET NCT03542773 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Completed | Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer NCT02041871 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumo NCT01678690 | InnoPharmax Inc. | EARLY_Phase 1 |
| Completed | Additive Homeopathy in Cancer Patients NCT01509612 | Medical University of Vienna | Phase 3 |
| Enrolling By Invitation | Chinese Population Health and Multimorbidity Study NCT07026370 | China-Japan Friendship Hospital | — |
| Unknown | The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress NCT01092247 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer NCT00165100 | Dana-Farber Cancer Institute | N/A |
| Completed | Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolesce NCT00412503 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 1 |